{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:55:44Z","timestamp":1790078144996,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s11920-017-0809-3","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T21:53:37Z","timestamp":1500501217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Valproic Acid in Women and Girls of Childbearing Age"],"prefix":"10.1007","volume":"19","author":[{"given":"Dorothy","family":"Gotlib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E.","family":"Kurlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"DeRiggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Riba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"809_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/bdra.23147","volume":"97","author":"DA Adedinsewo","year":"2013","unstructured":"\u2022\u2022 Adedinsewo DA, Thurman DJ, Luo Y-H, Williamson RS, Odewole OA, Oakley GP. Valproate prescriptions for nonepilepsy disorders in reproductive-age women. Birt Defects Res A Clin Mol Teratol. 2013;97:403\u20138. A review of nine million VPA prescriptions over 12 years and found that 74% of VPA prescriptions were for psychiatric disorders, and that use of this medication for reproductive-aged women tripled between the late 1990s and 2007.","journal-title":"Birt Defects Res A Clin Mol Teratol"},{"key":"809_CR2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/bdra.23177","volume":"97","author":"KJ Denny","year":"2013","unstructured":"Denny KJ, Jeanes A, Fathe K, Finnell RH, Taylor SM, Woodruff TM. Neural tube defects, folate, and immune modulation. Birt Defects Res A Clin Mol Teratol. 2013;97:602\u20139.","journal-title":"Birt Defects Res A Clin Mol Teratol"},{"key":"809_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4088\/JCP.15m10046","volume":"77","author":"D Gotlib","year":"2016","unstructured":"Gotlib D, Perelstein E, Kurlander J, Zivin K, Riba M, Muzik M. Guideline adherence for mentally ill reproductive-aged women on treatment with valproic acid: a retrospective chart review. J Clin Psychiatry. 2016;77:527\u201334.","journal-title":"J Clin Psychiatry"},{"key":"809_CR4","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F, EURAP study group (2011) Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10:609\u2013617. VPA increases risk of causing multiple teratogenic effects.","DOI":"10.1016\/S1474-4422(11)70107-7"},{"key":"809_CR5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajmg.c.30306","volume":"157C","author":"SM Gilboa","year":"2011","unstructured":"Gilboa SM, Broussard CS, Devine OJ, Duwe KN, Flak AL, Boulet SL, et al. Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States. Am J Med Genet C Semin Med Genet. 2011;157C:234\u201346.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"809_CR6","doi-asserted-by":"crossref","unstructured":"Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev. 2014;","DOI":"10.1002\/14651858.CD010236.pub2"},{"key":"809_CR7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","volume":"73","author":"CL Harden","year":"2009","unstructured":"Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73:133\u201341.","journal-title":"Neurology"},{"key":"809_CR8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","volume":"64","author":"DF Wyszynski","year":"2005","unstructured":"Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB, et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology. 2005;64:961\u20135.","journal-title":"Neurology"},{"key":"809_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","volume":"81","author":"K Meador","year":"2008","unstructured":"Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res. 2008;81:1\u201313.","journal-title":"Epilepsy Res"},{"key":"809_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cpt.158","volume":"98","author":"M Tanoshima","year":"2015","unstructured":"Tanoshima M, Kobayashi T, Tanoshima R, Beyene J, Koren G, Ito S. Risks of congenital malformations in offspring exposed to valproic acid in utero: a systematic review and cumulative meta-analysis. Clin Pharmacol Ther. 2015;98:417\u201341.","journal-title":"Clin Pharmacol Ther"},{"key":"809_CR11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/s-0035-1556741","volume":"4","author":"EE Gerard","year":"2015","unstructured":"Gerard EE, Meador KJ. An update on maternal use of antiepileptic medications in pregnancy and neurodevelopment outcomes. J Pediatr Genet. 2015;4:94\u2013110.","journal-title":"J Pediatr Genet"},{"key":"809_CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.0000000000002119","volume":"86","author":"KJ Meador","year":"2016","unstructured":"Meador KJ, Loring DW. Developmental effects of antiepileptic drugs and the need for improved regulations. Neurology. 2016;86:297\u2013306.","journal-title":"Neurology"},{"key":"809_CR13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S1092852913000990","volume":"19","author":"S Gentile","year":"2014","unstructured":"Gentile S. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions. CNS Spectr. 2014;19:305\u201315.","journal-title":"CNS Spectr"},{"key":"809_CR14","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"\u2022\u2022 Christensen J, Gr\u00f8nborg TK, S\u00f8rensen MJ, Schendel D, Parner ET, Pedersen LH, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309:1696\u2013703. Children exposed to VPA in utero have increased risk for lower intelligence, increased rates of autism, and behavioral problems.","journal-title":"JAMA"},{"key":"809_CR15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","volume":"56","author":"T Tomson","year":"2015","unstructured":"Tomson T, Marson A, Boon P, Canevini MP, Covanis A, Gaily E, et al. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia. 2015;56:1006\u201319.","journal-title":"Epilepsia"},{"key":"809_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1196\/annals.1429.030","volume":"1135","author":"H Joffe","year":"2008","unstructured":"Joffe H, Hayes FJ. Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents. Ann N Y Acad Sci. 2008;1135:219\u201329.","journal-title":"Ann N Y Acad Sci"},{"key":"809_CR17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","volume":"28","author":"S Svalheim","year":"2015","unstructured":"\u2022\u2022 Svalheim S, Sveberg L, Mochol M, Taub\u00f8ll E. Interactions between antiepileptic drugs and hormones. Seizure. 2015;28:12\u20137. VPA use in women and girls leads to increased risk of PCOS, menstrual abnormalities, infertility, acne, osteoporosis, and obesity.","journal-title":"Seizure"},{"key":"809_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2298\/MPNS1604121O","volume":"69","author":"M Okanovi\u0107","year":"2016","unstructured":"Okanovi\u0107 M, Zivanovi\u0107 O. Valproate, bipolar disorder and polycystic ovarian syndrome. Med Pregl. 2016;69:121\u20136.","journal-title":"Med Pregl"},{"key":"809_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4103\/0972-2327.179973","volume":"19","author":"LG Viswanathan","year":"2016","unstructured":"Viswanathan LG, Satishchandra P, Bhimani BC, Reddy JY, Rama Murthy BS, Subbakrishna DK, et al. Polycystic ovary syndrome in patients on antiepileptic drugs. Ann Indian Acad Neurol. 2016;19:339\u201343.","journal-title":"Ann Indian Acad Neurol"},{"key":"809_CR20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00228-014-1748-0","volume":"70","author":"R Davanzo","year":"2014","unstructured":"Davanzo R, Bua J, Paloni G, Facchina G. Breastfeeding and migraine drugs. Eur J Clin Pharmacol. 2014;70:1313\u201324.","journal-title":"Eur J Clin Pharmacol"},{"key":"809_CR21","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.euroneuro.2016.08.008","volume":"26","author":"I Pacchiarotti","year":"2016","unstructured":"Pacchiarotti I, Le\u00f3n-Caballero J, Murru A, et al. Mood stabilizers and antipsychotics during breastfeeding: focus on bipolar disorder. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2016;26:1562\u201378.","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"809_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/bdi.12398","volume":"18","author":"F Uguz","year":"2016","unstructured":"Uguz F, Sharma V. Mood stabilizers during breastfeeding: a systematic review of the recent literature. Bipolar Disord. 2016;18:325\u201333.","journal-title":"Bipolar Disord"},{"key":"809_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20230","volume":"20","author":"I Petersen","year":"2016","unstructured":"Petersen I, McCrea RL, Sammon CJ, Osborn DPJ, Evans SJ, Cowen PJ, et al. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess Winch Engl. 2016;20:1\u2013176.","journal-title":"Health Technol Assess Winch Engl"},{"key":"809_CR24","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423363","volume-title":"APA practice guidelines for the treatment of psychiatric disorders: comprehensive guidelines and guideline watches","author":"American Psychiatric Association","year":"2006","unstructured":"American Psychiatric Association. APA practice guidelines for the treatment of psychiatric disorders: comprehensive guidelines and guideline watches. 1st ed. Arlington: American Psychiatric Association; 2006.","edition":"1"},{"key":"809_CR25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/AOG.0b013e31816fd910","volume":"111","author":"ACOG Committee on Practice Bulletins--Obstetrics","year":"2008","unstructured":"ACOG Committee on Practice Bulletins--Obstetrics. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 2008;111:1001\u201320.","journal-title":"Obstet Gynecol"},{"key":"809_CR26","unstructured":"\u2022\u2022 Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care | key-priorities-for-implementation | Guidance and guidelines | NICE. http:\/\/www.nice.org.uk\/guidance\/cg185\/chapter\/key-priorities-for-implementation . Accessed 5 Jan 2015. Most rigid of the relevant guidelines, \u201cDo not offer VPA to young girls or women of childbearing potential.\u201d"},{"key":"809_CR27","unstructured":"The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care | 1-recommendations | Guidance and guidelines | NICE. http:\/\/www.nice.org.uk\/guidance\/cg137\/chapter\/1-recommendations#women-and-girls-with-epilepsy . Accessed 20 Apr 2015."},{"key":"809_CR28","unstructured":"European Medicines Agency - Human medicines - Valproate and related substances. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Valproate_and_related_substances\/human_referral_prac_000032.jsp&mid=WC0b01ac05805c516f . Accessed 30 Mar 2017."},{"key":"809_CR29","doi-asserted-by":"crossref","first-page":"hzt003","DOI":"10.1093\/biohorizons\/hzt003","volume":"6","author":"KA Lloyd","year":"2013","unstructured":"Lloyd KA. A scientific review: mechanisms of valproate-mediated teratogenesis. Biosci Horiz. 2013;6:hzt003.","journal-title":"Biosci Horiz"},{"key":"809_CR30","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","volume":"378","author":"A Cipriani","year":"2011","unstructured":"Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378:1306\u201315.","journal-title":"Lancet"},{"key":"809_CR31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00737-007-0175-y","volume":"10","author":"A Wieck","year":"2007","unstructured":"Wieck A, Rao S, Sein K, Haddad PM. A survey of antiepileptic prescribing to women of childbearing potential in psychiatry. Arch Womens Ment Health. 2007;10:83\u20135.","journal-title":"Arch Womens Ment Health"},{"key":"809_CR32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.siny.2013.11.008","volume":"19","author":"V Kancherla","year":"2014","unstructured":"Kancherla V, Oakley GP Jr, Brent RL. Urgent global opportunities to prevent birth defects. Semin Fetal Neonatal Med. 2014;19:153\u201360.","journal-title":"Semin Fetal Neonatal Med"},{"key":"809_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/157340411794474739","volume":"7","author":"A Wieck","year":"2011","unstructured":"Wieck A. The use of anti-epileptic medication in women with affective disorders in early and late pregnancy and during breastfeeding. Curr Womens Health Rev. 2011;7:50\u20137.","journal-title":"Curr Womens Health Rev"},{"key":"809_CR34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","volume":"50","author":"CL Harden","year":"2009","unstructured":"Harden CL, Pennell PB, Koppel BS, et al. Management issues for women with epilepsy\u2014focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: report of the quality standards subcommittee and therapeutics and technology assessment Subcommittee of the American Academy of neurology and the American Epilepsy Society. Epilepsia. 2009;50:1247\u201355.","journal-title":"Epilepsia"},{"key":"809_CR35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1471-244X-13-234","volume":"13","author":"J Langan","year":"2013","unstructured":"\u2022\u2022 Langan J, Perry A, Oto M. Teratogenic risk and contraceptive counselling in psychiatric practice: analysis of anticonvulsant therapy. BMC Psychiatry. 2013;13:234. This paper describes a lack of counseling and cautionary measures taken when physicians prescribe VPA to women of childbearing potential.","journal-title":"BMC Psychiatry"},{"key":"809_CR36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","volume":"33","author":"F Habermann","year":"2013","unstructured":"Habermann F, Fritzsche J, Fuhlbr\u00fcck F, Wacker E, Allignol A, Weber-Schoendorfer C, et al. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol. 2013;33:453\u201362.","journal-title":"J Clin Psychopharmacol"},{"key":"809_CR37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archgenpsychiatry.2012.160","volume":"69","author":"KC Johnson","year":"2012","unstructured":"Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport D. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012;69:787\u201394.","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 1","key":"809_CR38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-5618.2005.00190.x","volume":"7","author":"V Curtis","year":"2005","unstructured":"Curtis V. Women are not the same as men: specific clinical issues for female patients with bipolar disorder. Bipolar Disord. 2005;7(Suppl 1):16\u201324.","journal-title":"Bipolar Disord"},{"issue":"Suppl 9","key":"809_CR39","first-page":"4","volume":"68","author":"LS Cohen","year":"2007","unstructured":"Cohen LS. Treatment of bipolar disorder during pregnancy. J Clin Psychiatry. 2007;68(Suppl 9):4\u20139.","journal-title":"J Clin Psychiatry"},{"key":"809_CR40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jad.2014.11.058","volume":"174","author":"A Karanti","year":"2015","unstructured":"\u2022\u2022 Karanti A, Bobeck C, Osterman M, Kardell M, Tidemalm D, Runeson B, et al. Gender differences in the treatment of patients with bipolar disorder: a study of 7354 patients. J Affect Disord. 2015;174:303\u20139. Over the course of this study, VPA use in Floridian women on Medicaid was decreased for epilepsy but not for other indications.","journal-title":"J Affect Disord"},{"key":"809_CR41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jad.2016.01.043","volume":"195","author":"A Karanti","year":"2016","unstructured":"Karanti A, Kardell M, Lundberg U, Land\u00e9n M. Changes in mood stabilizer prescription patterns in bipolar disorder. J Affect Disord. 2016;195:50\u20136.","journal-title":"J Affect Disord"},{"key":"809_CR42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.seizure.2012.04.014","volume":"21","author":"JM Nicholas","year":"2012","unstructured":"Nicholas JM, Ridsdale L, Richardson MP, Ashworth M, Gulliford MC. Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the general practice research database. Seizure. 2012;21:466\u201370.","journal-title":"Seizure"},{"key":"809_CR43","first-page":"499","volume":"88","author":"N Farahi","year":"2013","unstructured":"Farahi N, Zolotor A. Recommendations for preconception counseling and care. Am Fam Physician. 2013;88:499\u2013506.","journal-title":"Am Fam Physician"},{"issue":"Suppl 2","key":"809_CR44","doi-asserted-by":"crossref","first-page":"S598","DOI":"10.1007\/s11606-012-2240-0","volume":"28","author":"EB Schwarz","year":"2013","unstructured":"Schwarz EB, Mattocks K, Brandt C, Borrero S, Zephyrin LC, Bathulapalli H, et al. Counseling of female veterans about risks of medication-induced birth defects. J Gen Intern Med. 2013;28(Suppl 2):S598\u2013603.","journal-title":"J Gen Intern Med"},{"key":"809_CR45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1176\/ps.62.2.pss6202_0218","volume":"62","author":"KL Wisner","year":"2011","unstructured":"Wisner KL, Leckman-Westin E, Finnerty M, Essock SM. Valproate prescription prevalence among women of childbearing age. Psychiatr Serv Wash DC. 2011;62:218\u201320.","journal-title":"Psychiatr Serv Wash DC"},{"key":"809_CR46","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1176\/ps.2009.60.12.1595","volume":"60","author":"SM Essock","year":"2009","unstructured":"Essock SM, Covell NH, Leckman-Westin E, Lieberman JA, Sederer LI, Kealey E, et al. Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state. Psychiatr Serv Wash DC. 2009;60:1595\u2013602.","journal-title":"Psychiatr Serv Wash DC"},{"key":"809_CR47","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2105\/AJPH.2013.301416","volume":"104","author":"LB Finer","year":"2014","unstructured":"Finer LB, Zolna MR. Shifts in intended and unintended pregnancies in the United States, 2001\u20132008. Am J Public Health. 2014;104:S43\u20138.","journal-title":"Am J Public Health"},{"key":"809_CR48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00737-009-0060-y","volume":"12","author":"PV Magalh\u00e3es","year":"2009","unstructured":"Magalh\u00e3es PV, Da S, Kapczinski F, Kauer-Sant\u2019Anna M. Use of contraceptive methods among women treated for bipolar disorder. Arch Womens Ment Health. 2009;12:183\u20135.","journal-title":"Arch Womens Ment Health"},{"key":"809_CR49","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40263-014-0187-x","volume":"28","author":"HM Hamer","year":"2014","unstructured":"Hamer HM, Kostev K. Sociodemographic disparities in administration of antiepileptic drugs to adults with epilepsy in Germany: a retrospective, database study of drug prescriptions. CNS Drugs. 2014;28:753\u20139.","journal-title":"CNS Drugs"},{"key":"809_CR50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.seizure.2016.01.019","volume":"36","author":"S Murphy","year":"2016","unstructured":"Murphy S, Bennett K, Doherty CP. Prescribing trends for sodium valproate in Ireland. Seizure. 2016;36:44\u20138.","journal-title":"Seizure"},{"key":"809_CR51","doi-asserted-by":"publisher","unstructured":"Tomson T, Battino D, Perucca E. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol. 2015; doi: 10.1016\/S1474-4422(15)00314-2 .","DOI":"10.1016\/S1474-4422(15)00314-2"},{"key":"809_CR52","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/epi.13043","volume":"56","author":"S McCrary Van","year":"2015","unstructured":"Van McCrary S. Commentary: revised recommendation from CMDh on use of valproate in women is ethically incomplete and neglects the interests of women. Epilepsia. 2015;56:1020\u20132.","journal-title":"Epilepsia"},{"key":"809_CR53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.seizure.2014.10.004","volume":"24","author":"D Schmidt","year":"2015","unstructured":"Schmidt D. The dilemma of treating young women with generalized epilepsy with sodium valproate and how to get out of it. Seizure. 2015;24:143\u20134.","journal-title":"Seizure"},{"key":"809_CR54","first-page":"48","volume":"61","author":"S Begum","year":"2013","unstructured":"Begum S, Thomas SV. Women with epilepsy in reproductive age group: special issues and management strategies. J Assoc Physicians India. 2013;61:48\u201351.","journal-title":"J Assoc Physicians India"},{"key":"809_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-015-0646-1","volume":"18","author":"CL Wichman","year":"2016","unstructured":"Wichman CL. Managing your own mood lability: use of mood stabilizers and antipsychotics in pregnancy. Curr Psychiatry Rep. 2016;18:1.","journal-title":"Curr Psychiatry Rep"},{"key":"809_CR56","first-page":"165","volume":"159","author":"M Weber","year":"2003","unstructured":"Weber M, Dib M. Folic acid and prevention of anomalies of foetal neural tube closing in women treated for epilepsy. Rev Neurol (Paris). 2003;159:165\u201370.","journal-title":"Rev Neurol (Paris)"},{"key":"809_CR57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/bdra.23277","volume":"100","author":"K Fathe","year":"2014","unstructured":"Fathe K, Palacios A, Finnell RH. Brief report novel mechanism for valproate-induced teratogenicity. Birt Defects Res A Clin Mol Teratol. 2014;100:592\u20137.","journal-title":"Birt Defects Res A Clin Mol Teratol"},{"key":"809_CR58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12012-015-9316-0","volume":"16","author":"W-H Yu","year":"2016","unstructured":"Yu W-H, Ho Y-L, Huang P-T, Chu S-L, Tsai H-J, Liou H-H. The phosphorylation state of GSK3\u03b2 serine 9 correlated to the development of valproic acid-associated fetal cardiac teratogenicity, fetal VPA syndrome, rescued by folic acid administration. Cardiovasc Toxicol. 2016;16:34\u201345.","journal-title":"Cardiovasc Toxicol"},{"key":"809_CR59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.seizure.2016.05.007","volume":"40","author":"YC Kaplan","year":"2016","unstructured":"Kaplan YC, Abdelkader N. Valproate prescribing trends for non-epilepsy indications in women of reproductive age warrants effective measures and increased surveillance. Seizure. 2016;40:13\u20134.","journal-title":"Seizure"},{"key":"809_CR60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.yebeh.2015.12.002","volume":"55","author":"T Lavi-Blau","year":"2016","unstructured":"Lavi-Blau T, Ekstein D, Neufeld MY, Eyal S. Use of antiepileptic drugs during pregnancy and lactation: type of information provided by searching Google. Epilepsy Behav EB. 2016;55:113\u20139.","journal-title":"Epilepsy Behav EB"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-017-0809-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-017-0809-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-017-0809-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T12:32:27Z","timestamp":1750768347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-017-0809-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["809"],"URL":"https:\/\/doi.org\/10.1007\/s11920-017-0809-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731984832.793554071","asserted-by":"object"}]},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,20]]},"article-number":"58"}}